Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
General Pharmacology|January 1, 1991
Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor--nootropic agent adafenoxateS L Stancheva, L G AlovaGeneral Pharmacology|September 1, 1994
Biogenic monoamine uptake by rat brain synaptosomes during aging. Effects of nootropic drugsS L Stancheva, L G AlovaGeneral Pharmacology|November 1, 1993
Ginsenoside Rg1 inhibits the brain cAMP phosphodiesterase activity in young and aged ratsS L Stancheva, L G AlovaFarmakologiia I Toksikologiia|May 1, 1988
[Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats]S L Stancheva, L G AlovaGeneral Pharmacology|September 1, 1994
In vitro and in vivo effect of the nootropic agent adafenoxate on the 5-HT1 sites in different rat brain structuresC I Hadjiivanova, S L StanchevaActa Physiologica Et Pharmacologica Bulgarica|January 1, 1988
Effects of the nootropic agents adafenoxate and meclofenoxate on brain biogenic monoamines in aged ratsS L Stancheva, V D Petkov, V V PetkovGerontology|January 1, 1988
Age-related changes in brain neurotransmissionV D Petkov, V V Petkov, S L StanchevaGeneral Pharmacology|January 1, 1990
Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats)V D Petkov, S L Stancheva, L Tocuschieva, et al.Journal of Physiology, Paris|July 10, 1999
Effects of peptide and non-peptide antagonists of angiotensin II receptors on drinking behavior in ratsL G Alova, S L Stancheva, J Matsoukas, et al.General Pharmacology|January 1, 1991
Age-related changes of the effects of a group of nootropic drugs on the content of rat brain biogenic monoaminesS L Stancheva, V D Petkov, C I Hadjiivanova, et al.Pageof 2